That S-CDK cannot substitute for M-CDK for the completion of mitosis and cell division is compatible with a qualitative view of CDK cell cycle control, with S-CDK being unable to phosphorylate ...
Worldwide, more than a million breast cancer patients have been treated with cyclin-dependent kinase 4/6 (CDK4/6) inhibitors, which slow or stop the uncontrolled multiplication of cancer cells.
Coordination of DNA replication (S-phase) and cell division (M-phase) is achieved by sequential activation of enzymatic activities that oscillate throughout the cell division cycle. These activities ...
The following represents disclosure information provided by authors of this manuscript. All relationships are considered compensated unless otherwise noted. Relationships are self-held unless noted. I ...
Prognostic value of serum apolipoprotein B (ApoB) to apolipoprotein A-I (ApoA-I) ratio in hepatocellular carcinoma patients with transcatheter arterial chemoembolization treatment: propensity ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results